VRTX
EquitiesLiveTokenized Vertex Pharmaceuticals
Tokenized Vertex Pharmaceuticals, on-chain exposure to the underlying equity.
Key facts
- On-chain symbol
- VRTX
- Underlying
- VRTX
- Asset class
- Equities
- Custody
- Held at Flo Finance
- Chains
- Base, Arbitrum, Ethereum
- Distribution treatment
- Total return, accrued to NAV
- Attestation cadence
- Daily
- Issuer
- Flo Finance
- Backing
- 1:1 backed by the real underlying
How VRTX resolves to VRTX
Each VRTX on-chain represents a 1:1 claim on the underlying Vertex Pharmaceuticals held at an institutional custodian. The issuer and backing model are the same for every Flo token; only the underlying differs.
- 01
Issuance
Flo Finance issues VRTX as a tokenized Vertex Pharmaceuticals, 1:1 backed by the real underlying.
- 02
Custody
The underlying Vertex Pharmaceuticals is held at Flo Finance, an institutional custodian.
- 03
Settlement
VRTX settles on-chain on Base, Arbitrum, Ethereum. Cross-chain transfers route through Chainlink CCIP.
- 04
Attestation
Reserves are attested daily by an independent auditor and published on the Flo transparency surface.
Mint VRTX with one SDK call
Every Flo-issued token shares the same six SDK methods. Mint, redeem, supply, withdraw, borrow, repay.
POST /v1/mint
{
"asset": "VRTX",
"notional_usdc": "1000.00",
"slippage_bps": 50,
"settlement": {
"currency": "USDC",
"chain": "base"
}
}Where VRTX lives today
Flo distributes through partners. The same VRTX on-chain is the asset every partner integrates against; partner UIs may relabel it for their own brand.
Partner integrations in build
No live partner is distributing VRTX yet. Twelve integrations are in build across exchanges, wallets, fintechs, neobanks, and asset managers. Partners are listed here only after they ship.
Audits
Four independent firms, $250K bug bounty
Sherlock, Halborn, Cantina, and Cyfrin have audited the smart contracts that issue and settle VRTX. The same contracts power every Flo-issued token; one audit covers the catalogue.
Read the audit reports →Backing
1:1 backed by the real underlying
VRTX is issued by Flo Finance and 1:1 backed by real Vertex Pharmaceuticals held at institutional custodians. Reserves are attested daily and published on the Flo transparency surface.
Open the transparency page →Risks
VRTX carries the market risk of the underlying Vertex Pharmaceuticals, plus the structural risks common to every tokenized asset: custody concentration, smart-contract risk, and oracle dependency. Read the full risk disclosures on the Flo transparency surface before integrating or holding.